Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
Titel:
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies
Auteur:
Pommeret, F. Colomba, J. Bigenwald, C. Laparra, A. Bockel, S. Bayle, A. Michot, J.-M. Hueso, T. Albiges, L. Tiberghien, P. Marot, S. Jary, A. Lacombe, K. Barlesi, F. Griscelli, F. Colomba, E.